These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3128443)

  • 21. Inhibition of rat brain monoamine oxidase type A by 2-aminotetralin and tetrahydroisoquinoline analogues of dopamine.
    Feenstra MG; van der Velden T; Dijkstra D; Hommes OR; Horn AS
    Pharm Weekbl Sci; 1983 Aug; 5(4):131-3. PubMed ID: 6622205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipophilicity plays a major role in modulating the inhibition of monoamine oxidase B by 7-substituted coumarins.
    Carotti A; Altomare C; Catto M; Gnerre C; Summo L; De Marco A; Rose S; Jenner P; Testa B
    Chem Biodivers; 2006 Feb; 3(2):134-49. PubMed ID: 17193252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of adenochrome and vicasol on monoamine oxidase in some organs of rabbits].
    Petrianik VD
    Ukr Biokhim Zh; 1971; 43(2):225-8. PubMed ID: 5564633
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of monoamine oxidase by furazolidone in germfree rats.
    Yeung TC; Goldman P
    Biochem Pharmacol; 1981 Sep; 30(17):2496-7. PubMed ID: 21043255
    [No Abstract]   [Full Text] [Related]  

  • 26. [Manganese effect on monoamine oxidase activity].
    Levina EN; Chekunova MP
    Vopr Med Khim; 1969; 15(6):634-7. PubMed ID: 5366711
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on monoamine oxidase. 5. Enzymic differences in the monoamine oxidases in the brain and liver].
    Tatsuo F
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):393-8. PubMed ID: 4387722
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
    Neff NH; Yang HY; Fuentes JA
    Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
    [No Abstract]   [Full Text] [Related]  

  • 30. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased acetylcholinesterase activity in selected regions of rat brain after chronic (-)-deprenyl administration.
    Lakshmana MK; Jagadeesh S; Subhash MN
    Neurochem Res; 1996 Oct; 21(10):1209-12. PubMed ID: 8923482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antihistamine and antiserotonin action of 2 aminotetralin derivatives].
    Staneva-Stoĭcheva D; Chakurova L; Raĭnova L; Ilarĭonov I
    Eksp Med Morfol; 1979; 18(3):154-9. PubMed ID: 40787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of inhibitors on monoamine oxidase activity in mouse brain.
    Hall TR; Figueroa HR; Yurgens PB
    Pharmacol Res Commun; 1982 May; 14(5):443-53. PubMed ID: 6810387
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of Geriforte in vivo and in vitro on age-related enzyme changes in liver and brain of rats.
    Bardhan P; Sharma SK; Garg NK
    Indian J Exp Biol; 1985 Jun; 23(6):323-6. PubMed ID: 3000931
    [No Abstract]   [Full Text] [Related]  

  • 36. [The modification of the catalytic activity of mitochondrial monoaminoxidase and the suppression of the growth of experimental brain tumors].
    Baumanis EA; Gorkin VZ; Lisianyĭ NI; Kozhukhov AN
    Patol Fiziol Eksp Ter; 1990; (4):32-5. PubMed ID: 2080083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of monoamine oxidase inhibitors from Glycyrrhiza uralensis roots and the structure-activity relationship.
    Tanaka S; Kuwai Y; Tabata M
    Planta Med; 1987 Feb; 53(1):5-8. PubMed ID: 3575512
    [No Abstract]   [Full Text] [Related]  

  • 38. Aliphatic N-methylpropargylamines: monoamine oxidase-B inhibitors and antiapoptotic drugs.
    Boulton AA; Yu PH; Davis BA; Paterson IA; Li XM; Juorio AV; Durden DA; Dyck LE
    Adv Pharmacol; 1998; 42():308-11. PubMed ID: 9327902
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro and in vivo inhibition of rat liver, brain and muscle monoamine oxidase by chlorpromazine and imipramine.
    Arora RC; Meltzer HY
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):755-8. PubMed ID: 959672
    [No Abstract]   [Full Text] [Related]  

  • 40. Some aspects of monoamine oxidase pharmacology.
    Callingham BA
    Cell Biochem Funct; 1986 Apr; 4(2):99-108. PubMed ID: 3085974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.